跳至主要内容
临床试验/ITMCTR1900002699
ITMCTR1900002699尚未招募1 期

A research for the clinical validity of Diabetes decoction which was set up by national medical master professor Yan Dexin and was used for treating type 2 diabetes with spleen-deficiency and blood-stasis syndrome in the early period

Shanghai Traditional Chinese Medicine Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. FBG< 13.8mmol/L, HbA1c< 9.0%, BMI> 23kg/m2, HOMA-IR> 2.8.
  • 2. Aged 35-75 years.
  • 3. Patients with newly diagnosed type 2 diabetes or whose course of disease is less than 3 years received sulfonylureas and guanidine blood glucose drugs for more than 3 months and the stable dose of sulfonylureas and guanidine drugs for at least 1 month were not allowed to use insulin therapy or other drugs that affect glucose and lipid metabolism during the test period
  • 4. Spleen-deficiency and blood-stasis syndrome.
  • 5. Signed informed consent and volunteered to participate in the study.

排除标准

  • 1. A history of severe heart disease.
  • 2. There are serious chronic complications of diabetes.
  • 3. Recent acute infectious disease and acute complications of diabetes.
  • 4. Severe hypertension.
  • 5. The researchers evaluated it is inappropriate for inclusion.

研究者

发起方
Shanghai Traditional Chinese Medicine Hospital

相似试验